{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:30:37Z","timestamp":1780453837869,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"traditional chinese medicine bureau of guangdong province of china for arranged project of experiential prescription","award":["No. 20194010"],"award-info":[{"award-number":["No. 20194010"]}]},{"name":"scientific research project of traditional chinese medicine bureau of guangdong province of china","award":["No. 20212213"],"award-info":[{"award-number":["No. 20212213"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amending from ancient classic, Ziyin Tongluo Formula (ZYTLF) has been prescribed to treat postmenopausal osteoporosis (PMOP) for decades with good curative effect. However, the possible mechanisms of it are still unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ovariectomized rat model was established to validate the therapeutic effect of ZYTLF on PMOP by Micro-CT bone analysis and pathological observation. Subsequently, active ingredients of ZYTLF and corresponding putative targets were identified by online databases. Overlapping genes were first obtained from mining genes associated with PMOP and then overlapped them with the putative targets. Key genes were selected from the multiple constructed and analyzed networks. GO and KEGG pathway enrichment analysis were performed by importing the key genes to the DAVID database. Moreover, validation of the binding association between key targets and their corresponding active compounds were accomplished by AutoDock Tools and other software. Lastly, Enzyme linked immunosorbent assay (Elisa) detection and Western blot analysis were utilized to further explore the possible mechanism of ZYTLF on PMOP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>With 129 target genes interacting with PMOP, 92 active compounds of ZYTLF corresponded to 243 targets, and 50 key genes were chosen. Network analysis revealed the top 10 active ingredients, such as quercetin and kaempferol and the top 50 key genes, such as ER\u03b1, p38 MAPK, p-AKT and TGF-\u03b21. Enrichment analysis uncovered multiple signaling pathways, including estrogen signaling pathway, TNF signaling pathway, PI3K-Akt signaling pathway and MAPK signaling pathway. Furthermore, our finding of the foremost active compounds was tightly bound to the core proteins, which were verified by molecular docking analysis. Through experimental studies, we confirmed that the prescription of ZYTLF could ameliorate the OVX-induced bone loss, suppress the osteoclast activity and boost osteoblast ability through experimental studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The potential mechanisms and therapeutic effects of ZYTLF against PMOP may be ascribed to inhibition of osteoclast activity, boost of osteoblast activity and enhancement of the expression of ER\u03b1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13020-021-00503-5","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T09:02:48Z","timestamp":1631782968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potential mechanism of Ziyin Tongluo Formula in the treatment of postmenopausal osteoporosis: based on network pharmacology and ovariectomized rat model"],"prefix":"10.1186","volume":"16","author":[{"given":"Rong-Bin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-032X","authenticated-orcid":false,"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"10","key":"503_CR1","first-page":"1387","volume":"26","author":"S Fujiwara","year":"2016","unstructured":"Fujiwara S. Epidemiology of respiratory diseases and osteoporosis. Clin Calcium. 2016;26(10):1387\u201392.","journal-title":"Clin Calcium"},{"key":"503_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.69","author":"R Eastell","year":"2016","unstructured":"Eastell R, O\u2019Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016. https:\/\/doi.org\/10.1038\/nrdp.2016.69.","journal-title":"Nat Rev Dis Primers"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4158\/GL-2020-0524","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB. American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update executive summary. Endocr Pract. 2020;26:564\u201370. https:\/\/doi.org\/10.4158\/GL-2020-0524.","journal-title":"Endocr Pract"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jbmr.3757","volume":"34","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, Huang J, Wen Q, Hu R, Wang L, Ma Y, Fu X, Dong S, Cheng X. The prevalence of osteoporosis in china, a nationwide, multicenter DXA survey. J Bone Miner Res. 2019;34:1789\u201397. https:\/\/doi.org\/10.1002\/jbmr.3757.","journal-title":"J Bone Miner Res"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00198-015-3093-2","volume":"26","author":"L Si","year":"2015","unstructured":"Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010\u20132050. Osteoporos Int. 2015;26:1929\u201337. https:\/\/doi.org\/10.1007\/s00198-015-3093-2.","journal-title":"Osteoporos Int"},{"key":"503_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-018-0549-y","author":"F Yu","year":"2019","unstructured":"Yu F, Xia W. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 2019. https:\/\/doi.org\/10.1007\/s11657-018-0549-y.","journal-title":"Arch Osteoporos"},{"key":"503_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","volume":"142","author":"SH Tella","year":"2014","unstructured":"Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol. 2014;142:155\u201370. https:\/\/doi.org\/10.1016\/j.jsbmb.2013.09.008.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"503_CR8","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1002\/jcb.26550pmid:29227547","volume":"119","author":"GF Liu","year":"2018","unstructured":"Liu GF, Wang ZQ, Liu L, Zhang BT, Miao YY, Yu SN. A network meta-analysis on the short-term efficacy and adverse events of different anti-osteoporosis drugs for the treatment of postmenopausal osteoporosis. J Cell Biochem. 2018;119(6):4469\u201381. https:\/\/doi.org\/10.1002\/jcb.26550pmid:29227547.","journal-title":"J Cell Biochem"},{"issue":"5","key":"503_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5582\/bst.2017.01216","volume":"11","author":"J Lin","year":"2017","unstructured":"Lin J, Zhu J, Wang Y, Zhang N, Gober HJ, Qiu XM, Li DJ, Wang L. Chinese single herbs and active ingredients for postmenopausal osteoporosis: from preclinical evidence to action mechanism. Biosci Trends. 2017;11(5):496\u2013506. https:\/\/doi.org\/10.5582\/bst.2017.01216.","journal-title":"Biosci Trends"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","volume":"189","author":"ND Zhang","year":"2016","unstructured":"Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, Qin LP, Xin HL, Zhang QY, Li YM. Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic medicine discovery. J Ethnopharmacol. 2016;189:61\u201380. https:\/\/doi.org\/10.1016\/j.jep.2016.05.025.","journal-title":"J Ethnopharmacol"},{"issue":"14","key":"503_CR11","first-page":"108","volume":"11","author":"MS Chen","year":"2019","unstructured":"Chen MS, Zhang B, Zeng HB, Tang SD. Clinical study on treating postmenopausal osteoporosis of the ShenyinXu type with the Ziyin Tongluo prescription. Clin J Chine Med. 2019;11(14):108\u201310.","journal-title":"Clin J Chine Med"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jep.2017.01.021","volume":"198","author":"C Liu","year":"2017","unstructured":"Liu C, Ma R, Wang L, Zhu R, Liu H, Guo Y, Zhao B, Zhao S, Tang J, Li Y, Niu J, Fu M, Zhang D, Gao S. Rehmanniae Radix in osteoporosis: a review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J Ethnopharmacol. 2017;198:351\u201362. https:\/\/doi.org\/10.1016\/j.jep.2017.01.021.","journal-title":"J Ethnopharmacol"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bone.2015.01.002","volume":"74","author":"Q Huang","year":"2015","unstructured":"Huang Q, Gao B, Wang L, Zhang H, Li X, Shi J, Wang Z, Zhang J, Yang L, Luo Z, Liu J. Ophiopogonin D: a new herbal agent against osteoporosis. Bone. 2015;74:18\u201328. https:\/\/doi.org\/10.1016\/j.bone.2015.01.002.","journal-title":"Bone"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/molecules22091469","volume":"22","author":"B Chen","year":"2017","unstructured":"Chen B, Wang L, Li L, Zhu R, Liu H, Liu C, Ma R, Jia Q, Zhao D, Niu J, Fu M, Gao S, Zhang D. Fructus Ligustri Lucidi in osteoporosis: a review of its pharmacology, phytochemistry pharmacokinetics and safety. Molecules. 2017;22:1469. https:\/\/doi.org\/10.3390\/molecules22091469.","journal-title":"Molecules"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.7150\/ijbs.14151","volume":"12","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Lin Y, Zhao H, Guo Q, Yan C, Lin N. Revealing the effects of the herbal pair of Euphorbia kansui and glycyrrhiza on hepatocellular carcinoma ascites with integrating network target analysis and experimental validation. Int J Biol Sci. 2016;12:594\u2013606. https:\/\/doi.org\/10.7150\/ijbs.14151.","journal-title":"Int J Biol Sci"},{"key":"503_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11:110\u201320. https:\/\/doi.org\/10.1016\/S1875-5364(13)60037-0.","journal-title":"Chin J Nat Med"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/495840","volume":"2014","author":"H Li","year":"2014","unstructured":"Li H, Zhao L, Zhang B, Jiang Y, Wang X, Guo Y, Liu H, Li S, Tong X. A network pharmacology approach to determine active compounds and action mechanisms of Ge-Gen-Qin-Lian decoction for treatment of type 2 diabetes. eCAM. 2014;2014:1\u201312. https:\/\/doi.org\/10.1155\/2014\/495840.","journal-title":"eCAM"},{"key":"503_CR18","first-page":"165","volume":"7","author":"S Li","year":"2021","unstructured":"Li S. Network pharmacology evaluation method guidance\u2014draft. World J Tradit Chin Med. 2021;7:165\u20136.","journal-title":"World J Tradit Chin Med"},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia S, Bordoloi M. Molecular docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets. 2019;20:501\u201321. https:\/\/doi.org\/10.2174\/1389450119666181022153016.","journal-title":"Curr Drug Targets"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L. TCMSP: a database of systems pharmacology for medicine discovery from herbal medicines. J Cheminform. 2014;6:13. https:\/\/doi.org\/10.1186\/1758-2946-6-13.","journal-title":"J Cheminform"},{"key":"503_CR21","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1038\/srep21146","volume":"6","author":"Z Liu","year":"2016","unstructured":"Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, Diao L, Gu J, Wang W, Li D, He F. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci Rep. 2016;6:21146. https:\/\/doi.org\/10.1038\/srep21146.","journal-title":"Sci Rep"},{"issue":"D1","key":"503_CR22","doi-asserted-by":"publisher","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","volume":"46","author":"L Huang","year":"2018","unstructured":"Huang L, Xie D, Yiran Y, Liu H, Shi Y, Shi T, Wen C. TCMID 2.0: a comprehensive resource for TCM. Nucleic Acids Res. 2018;46(D1):D1117-20. https:\/\/doi.org\/10.1093\/nar\/gkx1028.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"503_CR23","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"The UniProt Consortium","year":"2019","unstructured":"The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506-15. https:\/\/doi.org\/10.1093\/nar\/gky1049.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"503_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/nar\/gkg050","volume":"31","author":"M Safran","year":"2003","unstructured":"Safran M. Human gene-centric databases at the weizmann institute of science: GeneCards, UDB, CroW 21 and HORDE. Nucleic Acids Res. 2003;31(1):142\u20136. https:\/\/doi.org\/10.1093\/nar\/gkg050.","journal-title":"Nucleic Acids Res"},{"key":"503_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.27","author":"JS Amberger","year":"2017","unstructured":"Amberger JS, Hamosh A. Searching online mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinform. 2017. https:\/\/doi.org\/10.1002\/cpbi.27.","journal-title":"Curr Protoc Bioinform"},{"key":"503_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1021","author":"J Pi\u00f1ero","year":"2019","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2019. https:\/\/doi.org\/10.1093\/nar\/gkz1021.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"503_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2018","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2018;18(2):623\u201332. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00702.","journal-title":"J Proteome Res"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/acs.jproteome.8b00702","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang Y, Li M, Wang JX, Pan Y, Wu FX. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67\u201372. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00702.","journal-title":"Biosystems"},{"issue":"D1","key":"503_CR29","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-13. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"503_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc"},{"issue":"1","key":"503_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313. https:\/\/doi.org\/10.1093\/nar\/gkn923.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"503_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cancers10110461","volume":"10","author":"JH Zheng","year":"2018","unstructured":"Zheng JH, Wu M, Wang HY, Li SS, Wang X, Li Y, Wang D, Li S. Network pharmacology to unveil the biological basis of health-strengthening herbal medicine in cancer treatment. Cancers. 2018;10(11):461. https:\/\/doi.org\/10.3390\/cancers10110461.","journal-title":"Cancers"},{"issue":"1\u20132","key":"503_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11010-011-0927-x","volume":"358","author":"R Babujanarthanam","year":"2011","unstructured":"Babujanarthanam R, Kavitha P, Rao USM, Pandian MR. Quercitrin a bioflavonoid improves the antioxidant status in streptozotocin: induced diabetic rat tissues. Mol Cell Biochem. 2011;358(1\u20132):121\u20139. https:\/\/doi.org\/10.1007\/s11010-011-0927-x.","journal-title":"Mol Cell Biochem"},{"key":"503_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1400-z","author":"AB Ward","year":"2018","unstructured":"Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol. 2018. https:\/\/doi.org\/10.1186\/s12957-018-1400-z.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"503_CR35","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.intimp.2008.07.006","volume":"8","author":"EA Cruz","year":"2008","unstructured":"Cruz EA, Da-Silva SAG, Muzitano MF, Silva PMR, Costa SS, Rossi-Bergmann B. Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. Int Immunopharmacol. 2008;8(12):1616\u201321. https:\/\/doi.org\/10.1016\/j.intimp.2008.07.006.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"503_CR36","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/ptr.3465","volume":"25","author":"JA Kim","year":"2011","unstructured":"Kim JA, Jung YS, Kim MY, Yang SY, Lee S, Kim YH. Protective effect of components isolated from Lindera erythrocarpa against oxidative stress-induced apoptosis of H9c2 cardiomyocytes. Phytother Res. 2011;25(11):1612\u20137. https:\/\/doi.org\/10.1002\/ptr.3465.","journal-title":"Phytother Res"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.biopha.2017.02.073","volume":"89","author":"LZ Xing","year":"2017","unstructured":"Xing LZ, Ni HJ, Wang YL. Quercitrin attenuates osteoporosis in ovariectomized rats by regulating mitogen-activated protein kinase (MAPK) signaling pathways. Biomed Pharmacother. 2017;89:1136\u201341. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.073.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"503_CR38","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.pharep.2017.05.002","volume":"69","author":"B Nowak","year":"2017","unstructured":"Nowak B, Matuszewska A, Nikodem A, Filipiak J, Landw\u00f3jtowicz M, Sadanowicz E, J\u0119drzejuk D, Rzeszutko M, Zduniak K, Piasecki T, Kowalski P, Dziewiszek W, Merwid-L\u0105d A, Trocha M, Soza\u0144ski T, Kwiatkowska J, Bolanowski M, Szel\u0105g A. Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia. Pharmacol Rep. 2017;69(5):1113\u20139. https:\/\/doi.org\/10.1016\/j.pharep.2017.05.002.","journal-title":"Pharmacol Rep"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2147\/DDDT.S227738","volume":"13","author":"SK Wong","year":"2019","unstructured":"Wong SK, Chin KY, Ima-Nirwana S. The osteoprotective effects of kaempferol: the evidence from in vivo and in vitro studies. Drug Des Devel Ther. 2019;13:3497\u2013514. https:\/\/doi.org\/10.2147\/DDDT.S227738.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"503_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jbmr.2082","volume":"29","author":"KM Melville","year":"2014","unstructured":"Melville KM, Kelly NH, Khan SA, Schimenti JC, Ross FP, Main RP, Meulen MCH. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J Bone Miner Res. 2014;29(2):370\u20139. https:\/\/doi.org\/10.1002\/jbmr.2082.","journal-title":"J Bone Miner Res"},{"key":"503_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopha.2018.03.080","volume":"102","author":"L Zha","year":"2018","unstructured":"Zha L, He L, Liang YJ, Qin H, Yu B, Chang LL, Xue L. TNF-\u03b1 contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. Biomed Pharmacother. 2018;102:369\u201374. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.080.","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"503_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11010-015-2391-5","volume":"405","author":"A Shoukry","year":"2015","unstructured":"Shoukry A, Shalaby SM, Etewa RL, Ahmed HS, Abdelrahman HM. Association of estrogen receptor beta and estrogen-related receptor alpha gene polymorphisms with bone mineral density in postmenopausal women. Mol Cell Biochem. 2015;405(1\u20132):23\u201331. https:\/\/doi.org\/10.1007\/s11010-015-2391-5.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"503_CR43","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1210\/en.2006-0729","volume":"147","author":"K Moriarty","year":"2006","unstructured":"Moriarty K, Kim KH, Bender JR. Estrogen receptor-mediated rapid signaling. Endocrinology. 2006;147(12):5557\u201363. https:\/\/doi.org\/10.1210\/en.2006-0729.","journal-title":"Endocrinology"},{"key":"503_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.108228","volume":"74","author":"AR Sharma","year":"2019","unstructured":"Sharma AR, Nam JS. Kaempferol stimulates WNT\/\u03b2-catenin signaling pathway to induce differentiation of osteoblasts. J Nutri Biochem. 2019;74: 108228. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.108228.","journal-title":"J Nutri Biochem"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-021-00503-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00503-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T09:15:28Z","timestamp":1631783728000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-021-00503-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s13020-021-00503-5","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}